Vincerx Other Operating Expenses from 2010 to 2024

VINC Stock  USD 0.70  0.01  1.45%   
Vincerx Pharma's Other Operating Expenses is increasing over the years with slightly volatile fluctuation. Other Operating Expenses is expected to dwindle to about 41.2 M. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2010-12-31
Previous Quarter
42.6 M
Current Value
41.2 M
Quarterly Volatility
25.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vincerx Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vincerx main balance sheet or income statement drivers, such as Depreciation And Amortization of 960.8 K, Selling General Administrative of 12.9 M or Selling And Marketing Expenses of 16.4 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.35. Vincerx financial statements analysis is a perfect complement when working with Vincerx Pharma Valuation or Volatility modules.
  
This module can also supplement various Vincerx Pharma Technical models . Check out the analysis of Vincerx Pharma Correlation against competitors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

Latest Vincerx Pharma's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Vincerx Pharma over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vincerx Pharma. It is also known as Vincerx Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Vincerx Pharma's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vincerx Pharma's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Vincerx Other Operating Expenses Regression Statistics

Arithmetic Mean15,246,825
Geometric Mean426,907
Coefficient Of Variation167.40
Mean Deviation20,873,477
Median45,000
Standard Deviation25,522,934
Sample Variance651.4T
Range71.1M
R-Value0.74
Mean Square Error318.4T
R-Squared0.55
Significance0
Slope4,217,852
Total Sum of Squares9119.9T

Vincerx Other Operating Expenses History

202441.2 M
202342.6 M
202271.1 M
202162.7 M
202010.7 M

About Vincerx Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Vincerx Pharma income statement, its balance sheet, and the statement of cash flows. Vincerx Pharma investors use historical funamental indicators, such as Vincerx Pharma's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Vincerx Pharma investors may use each financial statement separately, they are all related. The changes in Vincerx Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vincerx Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vincerx Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vincerx Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Operating Expenses42.6 M41.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:
Check out the analysis of Vincerx Pharma Correlation against competitors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Vincerx Stock analysis

When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Vincerx Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.89)
Return On Assets
(0.69)
Return On Equity
(1.36)
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.